Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Optimization of proximity ligation assay (PLA) for detection of protein interactions and fusion proteins in non-adherent cells: application to pre-B lymphocytes.

Debaize L, Jakobczyk H, Rio AG, Gandemer V, Troadec MB.

Mol Cytogenet. 2017 Jul 20;10:27. doi: 10.1186/s13039-017-0328-2. eCollection 2017.

2.

Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.

Sun C, Chang L, Zhu X.

Oncotarget. 2017 May 23;8(21):35445-35459. doi: 10.18632/oncotarget.16367. Review.

3.

Role of RUNX1 in hematological malignancies.

Sood R, Kamikubo Y, Liu P.

Blood. 2017 Apr 13;129(15):2070-2082. doi: 10.1182/blood-2016-10-687830. Epub 2017 Feb 8. Review.

PMID:
28179279
4.

Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

Bauer E, Schlederer M, Scheicher R, Horvath J, Aigner P, Schiefer AI, Kain R, Regele H, Hoermann G, Steiner G, Kenner L, Sexl V, Villunger A, Moriggl R, Stoiber D.

Oncotarget. 2016 Mar 15;7(11):12191-205. doi: 10.18632/oncotarget.7687.

5.

Current Role of Genetics in Hematologic Malignancies.

Prakash G, Kaur A, Malhotra P, Khadwal A, Sharma P, Suri V, Varma N, Varma S.

Indian J Hematol Blood Transfus. 2016 Mar;32(1):18-31. doi: 10.1007/s12288-015-0584-4. Epub 2015 Sep 16. Review.

6.

Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.

Eto K, Kunishima S.

Blood. 2016 Mar 10;127(10):1234-41. doi: 10.1182/blood-2015-07-607903. Epub 2016 Jan 19. Review.

7.

Epigenetic deregulation in pediatric acute lymphoblastic leukemia.

Chatterton Z, Morenos L, Mechinaud F, Ashley DM, Craig JM, Sexton-Oates A, Halemba MS, Parkinson-Bates M, Ng J, Morrison D, Carroll WL, Saffery R, Wong NC.

Epigenetics. 2014 Mar;9(3):459-67. doi: 10.4161/epi.27585. Epub 2014 Jan 6.

8.

Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.

Kaindl U, Morak M, Portsmouth C, Mecklenbräuker A, Kauer M, Zeginigg M, Attarbaschi A, Haas OA, Panzer-Grümayer R.

Leukemia. 2014 Mar;28(3):600-8. doi: 10.1038/leu.2013.345. Epub 2013 Nov 18.

9.

The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods.

Linka Y, Ginzel S, Krüger M, Novosel A, Gombert M, Kremmer E, Harbott J, Thiele R, Borkhardt A, Landgraf P.

Blood Cancer J. 2013 Oct 11;3:e151. doi: 10.1038/bcj.2013.48.

10.

Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.

Harder L, Eschenburg G, Zech A, Kriebitzsch N, Otto B, Streichert T, Behlich AS, Dierck K, Klingler B, Hansen A, Stanulla M, Zimmermann M, Kremmer E, Stocking C, Horstmann MA.

J Exp Med. 2013 Oct 21;210(11):2289-304. doi: 10.1084/jem.20130497. Epub 2013 Sep 30.

11.

Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Kar A, Gutierrez-Hartmann A.

Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):522-43. doi: 10.3109/10409238.2013.838202. Epub 2013 Sep 25. Review.

12.

Clone-specific secondary aberrations are not detected in neonatal blood spots of children with ETV6-RUNX1-positive leukemia.

Morak M, Meyer C, Marschalek R, Mann G, Haas OA, Panzer-Grümayer R.

Haematologica. 2013 Sep;98(9):e108-10. doi: 10.3324/haematol.2013.090860. No abstract available.

13.

Chromosomal Aberrations in ETV6/RUNX1-positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization.

Zakaria Z, Ahid MF, Ismail A, Keoh TS, Nor NM, Kamaluddin NR, Esa E, Yuen LK, Rahman EJ, Osman R.

Mol Cytogenet. 2012 Nov 15;5(1):41. doi: 10.1186/1755-8166-5-41.

14.

Cancer cell metabolism: one hallmark, many faces.

Cantor JR, Sabatini DM.

Cancer Discov. 2012 Oct;2(10):881-98. doi: 10.1158/2159-8290.CD-12-0345. Epub 2012 Sep 25. Review.

15.

Tyrosyl phosphorylation toggles a Runx1 switch.

Neel BG, Speck NA.

Genes Dev. 2012 Jul 15;26(14):1520-6. doi: 10.1101/gad.198051.112.

16.

RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Lam K, Zhang DE.

Front Biosci (Landmark Ed). 2012 Jan 1;17:1120-39. Review.

17.

Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity.

Thathia SH, Ferguson S, Gautrey HE, van Otterdijk SD, Hili M, Rand V, Moorman AV, Meyer S, Brown R, Strathdee G.

Haematologica. 2012 Mar;97(3):371-8. doi: 10.3324/haematol.2011.049593. Epub 2011 Nov 4.

18.

The DAC system and associations with acute leukemias and myelodysplastic syndromes.

Bug G, Ottmann OG.

Invest New Drugs. 2010 Dec;28 Suppl 1:S36-49. doi: 10.1007/s10637-010-9595-z. Epub 2010 Dec 14.

19.

TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.

Diakos C, Zhong S, Xiao Y, Zhou M, Vasconcelos GM, Krapf G, Yeh RF, Zheng S, Kang M, Wiencke JK, Pombo-de-Oliveira MS, Panzer-Grümayer R, Wiemels JL.

Blood. 2010 Dec 2;116(23):4885-93. doi: 10.1182/blood-2009-02-206706. Epub 2010 Aug 31.

20.

Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.

Leclerc GJ, Sanderson C, Hunger S, Devidas M, Barredo JC.

Leuk Res. 2010 Dec;34(12):1601-9. doi: 10.1016/j.leukres.2010.05.012. Epub 2010 Jun 9.

Supplemental Content

Support Center